Vytorin Won’t Be ENHANCEd By Part D In 2009: Formulary Review

Three of the leading Medicare Part D sponsors will not cover Merck/Schering-Plough's Vytorin in their stand-alone drug plans in 2009, and much of the blame can probably be laid on the disappointing results of the ENHANCE study earlier this year